Trials / Completed
CompletedNCT06529627
GDF-8 Levels in ICSI Cycles
Effect of Growth Differentiation Factor - 8 (GDF-8) on Pregnancy Rates in GnRH-agonist ICSI Cycles: A Prospective Cohort Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- University of Alexandria · Academic / Other
- Sex
- Female
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to investigate the role of GDF-8 in regulating progesterone levels during controlled ovarian stimulation in patients undergoing ICSI-ET and to evaluate its effects on pregnancy rates. The main questions are * Does serum GDF-8 correlate with serum Progesterone levels during ovarian stimulation? * Does serum GDF-8 serum level at different time-points during ovarian stimulation correlate with pregnancy rate? participants will undergo ICSI-ET cycle using the long GnRH-agonist protocol and serum levels of GDF-8 and progesterone will be measured at three time-points during the trial: on day of hCG trigger administration, on day of oocyte pickup, and 14 days after embryo transfer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Long Gn-RH agonist protocol - Intracytoplasmic Sperm Injection | pituitary downregulation with GnRH agonist - ovarian stimulation with exogenous gonadotropin - hCG adminstration as trigger of oocyte maturation Oocyte retriveal via transvaginal ultrasound guided aspiration embryo transfer progesterone as luteal phase support |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2023-12-15
- Completion
- 2024-01-31
- First posted
- 2024-07-31
- Last updated
- 2024-07-31
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06529627. Inclusion in this directory is not an endorsement.